Variants in the nuclear-encoded OPA1 gene have been identified in ∼70% of ADOA cases.2,4,5 To date, over 400 distinct and likely pathogenic variants have been identified.5 About 50% of OPA1 mutations result in premature termination of translation, resulting in null alleles. The gene discussed is OPA1; the disease is autosomal dominant optic atrophy.